DNA Testing Is a Slippery Slope
By Russell Saunders,
The Daily Beast
| 04. 14. 2015
Untitled Document
Let’s say you have a whole lot of money.
Let’s say you have so much money that, even after you’ve purchased a basketball team and a chain of movie theaters, you still have enough cash left over to invest in a maverick approach to your own health care. Should you sink an unspecified sum into ordering every test you can find in the off chance that sooner or later you’re going to detect something valuable?
Mark Cuban says “yes.”
In a series of tweets posted at the beginning of this month, the media baron and basketball franchisee admonished his followers that, if they were sufficiently affluent, they should order blood tests for “everything available” on a quarterly basis in order to establish a baseline for their own health. In the event of some deviation from the any given person’s aggregate normal values, it might detect some abnormality earlier than it would otherwise be found when it started creating symptoms.
Looking at Cuban’s page now, it seems the tweets in question from April 1 have gone missing. But...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Lauren Hammer Breslow and Vanessa Smith, Bill of Health | 01.28.2026
On Jan. 24, 2026, the New York Times reported that DNA sequences contributed by children and families to support a federal effort to understand adolescent brain development were later co-opted by other researchers and used to publish “race science”...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...